287 related articles for article (PubMed ID: 319355)
1. Controlled comparison of amikacin and gentamicin.
Smith CR; Baughman KL; Edwards CQ; Rogers JF; Lietman PS
N Engl J Med; 1977 Feb; 296(7):349-53. PubMed ID: 319355
[TBL] [Abstract][Full Text] [Related]
2. Amikacin therapy of severe infections produced by gram-negative bacilli resistant to gentamicin.
Valdivieso M; Bodey GP
Am J Med Sci; 1977; 273(2):177-84. PubMed ID: 860733
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of hospital-acquired urinary infections with amikacin (author's transl)].
Weidner W; Nöske HD; Sziegoleit A; Schröder R; Leidenfrost U
Med Klin; 1979 Jul; 74(27):1071-6. PubMed ID: 470792
[TBL] [Abstract][Full Text] [Related]
4. [Amikacin in the treatment of hospital infections of the urinary tract caused by gram-negative bacilli resistant to gentamicin. Microbiological and clinical aspects].
Romoli E; Di Leonardo F; Giordano G; De Felice M; Cerquetti F; Vonmoos A
Minerva Urol; 1981; 33(2):85-90. PubMed ID: 7322100
[No Abstract] [Full Text] [Related]
5. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
Leonard JM; McGee ZA; Alford RH
Arch Intern Med; 1978 Feb; 138(2):201-5. PubMed ID: 415674
[TBL] [Abstract][Full Text] [Related]
6. Nephrotoxicity induced by gentamicin and amikacin.
Smith CR; Maxwell RR; Edwards CQ; Rogers JF; Lietman PS
Johns Hopkins Med J; 1978 Mar; 142(3):85-90. PubMed ID: 342789
[TBL] [Abstract][Full Text] [Related]
7. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
[TBL] [Abstract][Full Text] [Related]
8. Amikacin therapy for serious gram-negative infection.
Pollock AA; Berger SA; Richmond AS; Simberkoff MS; Rahal JJ
JAMA; 1977 Feb; 237(6):562-4. PubMed ID: 576282
[TBL] [Abstract][Full Text] [Related]
9. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.
Smith CR; Lipsky JJ; Laskin OL; Hellmann DB; Mellits ED; Longstreth J; Lietman PS
N Engl J Med; 1980 May; 302(20):1106-9. PubMed ID: 6988713
[TBL] [Abstract][Full Text] [Related]
10. Prospective comparative study of efficacy and toxicity of netilmicin and amikacin.
Bock BV; Edelstein PH; Meyer RD
Antimicrob Agents Chemother; 1980 Feb; 17(2):217-25. PubMed ID: 6992711
[TBL] [Abstract][Full Text] [Related]
11. [Amikacin and gentamicin: a controlled comparison (author's transl)].
Höffler D
Dtsch Med Wochenschr; 1978 Dec; 103(52):2071-5. PubMed ID: 365487
[TBL] [Abstract][Full Text] [Related]
12. Amikacin: in vitro bacteriological studies, levels in human serum, lung and heart tissue, and clinical results.
Faragó E; Kiss J; Gömöry A; Aranyosi J; Juhász I; Mihóczy L
Int J Clin Pharmacol Biopharm; 1979 Nov; 17(11):421-8. PubMed ID: 511416
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial spectrum, pharmacology, adverse effects, and therapeutic use of amikacin sulfate.
Pien FD; Ho PW
Am J Hosp Pharm; 1981 Jul; 38(7):981-9. PubMed ID: 7020413
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin.
Lerner SA; Schmitt BA; Seligsohn R; Matz GJ
Am J Med; 1986 Jun; 80(6B):98-104. PubMed ID: 3524221
[TBL] [Abstract][Full Text] [Related]
15. Amikacin therapy for serious gram-negative bacillary infections.
Meyer RD; Lewis RP; Carmalt ED; Finegold SM
Ann Intern Med; 1975 Dec; 83(6):790-800. PubMed ID: 1200524
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients: a randomized prospective trail.
Lau WK; Young LS; Black RE; Winston DJ; Linne SR; Weinstein RJ; Hewitt WL
Am J Med; 1977 Jun; 62(6):959-66. PubMed ID: 586099
[No Abstract] [Full Text] [Related]
17. Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancer.
Love LJ; Schimpff SC; Hahn DM; Young VM; Standiford HC; Bender JF; Fortner CL; Wiernik PH
Am J Med; 1979 Apr; 66(4):603-10. PubMed ID: 373439
[TBL] [Abstract][Full Text] [Related]
18. Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms.
Yu VL; Rhame FS; Pesanti EL; Axline SG
JAMA; 1977 Aug; 238(9):943-7. PubMed ID: 328950
[TBL] [Abstract][Full Text] [Related]
19. Amikacin therapy of gram-negative bacteremia.
Tally FP; Gorbach SL
Am J Med; 1977 Jun; 62(6):936-9. PubMed ID: 868909
[TBL] [Abstract][Full Text] [Related]
20. A prospective, randomized study of amikacin and gentamicin in serious infections with focus on efficacy, toxicity and duration of serum levels above the MIC.
Holm SE; Hill B; Löwestad A; Maller R; Vikerfors T
J Antimicrob Chemother; 1983 Oct; 12(4):393-402. PubMed ID: 6643334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
